Ashok Munjal
Department of Biochemistry and Genetics, Barkatullah University, Bhopal, Madhya Pradesh, India
LiveDNA: 91.12458
Rekha Khandia
Department of Biochemistry and Genetics, Barkatullah University, Bhopal, Madhya Pradesh, India
LiveDNA: 91.12456
Ruchi Tiwari
Department of Veterinary Microbiology and Immunology, College of Veterinary Sciences, UP Pandit Deen Dayal Upadhayay Pashu Chikitsa Vigyan Vishwavidyalay Evum Go-Anusandhan Sansthan, Mathura, Uttar Pradesh, India
LiveDNA: 91.10804
Sandip Chakraborty
Department of Veterinary Microbiology, College of Veterinary Sciences and Animal Husbandry, R.K. Nagar, 799008 West Tripura, India
LiveDNA: 91.16289
Kumaragurubaran Karthik
Central University Laboratory, Tamil Nadu Veterinary and Animal Sciences University, Chennai, Tamil Nadu, India
LiveDNA: 91.12455
Kuldeep Dhama
Division of Pathology, ICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, Uttar Pradesh, India
LiveDNA: 91.4710
International Journal of Pharmacology
Year: 2017 | Volume: 13 | Issue: 7 | Page No.: 667-676
PDF Fulltext XML References Citation
How to cite this article
Ashok Munjal, Rekha Khandia, Ruchi Tiwari, Sandip Chakraborty, Kumaragurubaran Karthik and Kuldeep Dhama, 2017. Advances in Designing and Developing Vaccines Against Zika Virus. International Journal of Pharmacology, 13: 667-676.
DOI: 10.3923/ijp.2017.667.676
URL: https://scialert.net/abstract/?doi=ijp.2017.667.676
DOI: 10.3923/ijp.2017.667.676
URL: https://scialert.net/abstract/?doi=ijp.2017.667.676
Leave a Comment
Your email address will not be published. Required fields are marked *
Article Trend
Total views 2936
References
- Lanciotti, R.S., O.L. Kosoy, J.J. Laven, J.O. Velez and A.J. Lambert et al., 2008. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerging Infect. Dis., 14: 1232-1239.
CrossRefDirect Link - Buathong, R., L. Hermann, B. Thaisomboonsuk, W. Rutvisuttinunt and C. Klungthong et al., 2015. Detection of Zika virus infection in Thailand, 2012-2014. Am. J. Trop. Med. Hyg., 93: 380-383.
CrossRefDirect Link - Oduyebo, T., E.R. Petersen, S.A. Rasmussen, P.S. Mead and D. Meaney-Delman et al., 2016. Update: Interim guidelines for health care providers caring for pregnant women and women of reproductive age with possible Zika virus exposure-United States, 2016. MMWR Morb. Mortal. Wkly. Rep., 65: 122-127.
CrossRefDirect Link - Berthet, N., E. Nakoune, B. Kamgang, B. Selekon and S.D. Declere et al., 2014. Molecular characterization of three Zika flaviviruses obtained from sylvatic mosquitoes in the central African republic. Vector-Borne Zoonotic Dis., 14: 862-865.
CrossRefDirect Link - Chang, C., K. Ortiz, A. Ansari and M.E. Gershwin, 2016. The Zika outbreak of the 21st century. J. Autoimmunity, 68: 1-13.
CrossRefDirect Link - Zanluca, C. and C.N.D. dos Santos, 2016. Zika virus-an overview. Microbes Infect., 18: 295-301.
CrossRefDirect Link - Bidet, K. and M.A. Garcia-Blanco, 2014. Flaviviral RNAs: Weapons and targets in the war between virus and host. Biochem. J., 462: 215-230.
CrossRefDirect Link - Faye, O., C.C.M. Freire, A. Iamarino, O. Faye and J.V.C. de Oliveira et al., 2014. Molecular evolution of Zika virus during its emergence in the 20th century. PloS Negl. Trop. Dis., Vol. 8.
CrossRefDirect Link - Musso, D., 2015. Zika virus transmission from French Polynesia to Brazil. Emerg. Infect. Dis., 21: 1887-1887.
CrossRef - Weaver, S.C., F. Costa, M.A. Garcia-Blanco, A.I. Ko and G.S. Ribeiro et al., 2016. Zika virus: History, emergence, biology and prospects for control. Antiviral Res., 130: 69-80.
CrossRefDirect Link - Weiskopf, D., D.J. Bangs, J. Sidney, R.V. Kolla and A.D. de Silva et al., 2015. Dengue virus infection elicits highly polarized CX3CR1+ cytotoxic CD4+ T cells associated with protective immunity. Proc. Natl. Acad. Sci. USA., 112: 4256-4263.
CrossRefPubMedDirect Link - Swanstrom, J.A., J.A. Plante, K.S. Plante, E.F. Young and E. McGowan et al., 2016. Dengue virus envelope dimer epitope monoclonal antibodies isolated from dengue patients are protective against Zika virus. MBio, 7: e01123-16.
CrossRefDirect Link - Whiteman M.C., L. Li, J.A. Wicker, R.M. Kinney and C. Huang et al., 2010. Development and characterization of non-glycosylated E and NS1 mutant viruses as a potential candidate vaccine for West Nile virus. Vaccine, 28: 1075-1083.
CrossRefPubMedDirect Link - Awasthi, S., 2016. Zika virus: Prospects for the development of vaccine and antiviral agents. J. Antivir. Antiretrovir., 8: 61-63.
CrossRefDirect Link - Durbin, A.P., 2016. Vaccine development for Zika virus-timelines and strategies. Semin. Reprod. Med., 34: 299-304.
CrossRefDirect Link - Dudley, D.M., M.T. Aliota, E.L. Mohr, A.M. Weiler and G. Lehrer-Brey et al., 2016. A rhesus macaque model of Asian-lineage Zika virus infection. Nat. Commun., Vol. 7.
CrossRefDirect Link - Pawitwar, S.S., S. Dhar, S. Tiwari, C.R. Ojha and J. Lapierre et al., 2017. Overview on the current status of Zika virus pathogenesis and animal related research. J. Neuroimmune Pharmacol., (In Press).
CrossRefDirect Link - Dowd, K.A., C.R. DeMaso, R.S. Pelc, S.D. Speer and A.R.Y. Smith et al., 2016. Broadly neutralizing activity of Zika virus-immune sera identifies a single viral serotype. Cell Rep., 16: 1485-1491.
CrossRefDirect Link - Dyer, O., 2016. Trials of Zika vaccine are set to begin in North America. BMJ., Vol. 353.
CrossRefDirect Link - Alera, M., L. Hermann, I.A. Tac-An, C. Klungthong and W. Rutvisuttinunt et al., 2015. Zika virus infection, Philippines, 2012. Emerg. Infect. Dis., 21: 722-724.
CrossRefDirect Link - Lanciotti, R.S., A.J. Lambert, M. Holodniy, S. Saavedra and L.D.C.C. Signor, 2016. Phylogeny of Zika virus in Western Hemisphere, 2015. Emerg. Infect. Dis., 22: 933-935.
CrossRefDirect Link - Wikan, N. and D.R. Smith, 2016. Zika virus: History of a newly emerging arbovirus. Lancet Infect. Dis., 16: e119-e126.
CrossRefDirect Link - Sumathy, K., B. Kulkarni, R.K. Gondu, S.K. Ponnuru and N. Bonguram, et al., 2017. Protective efficacy of Zika vaccine in AG129 mouse model. Scient. Rep., Vol. 7.
CrossRefDirect Link - Xie, X., Y. Yang, A.E. Muruato, J. Zou and C. Shan et al., 2017. Understanding Zika virus stability and developing a chimeric vaccine through functional analysis. mBio, Vol. 8.
CrossRefDirect Link - Dawe, B.E., C.A. Smalley, B.L. Tiner, D.W.C. Beasley and G.N. Milligan et al., 2016. Research and development of Zika virus vaccines. NPJ. Vaccines, Vol. 1.
CrossRefDirect Link - Guy, B., M. Saville and J. Lang, 2010. Development of sanofi pasteur tetravalent dengue vaccine. Hum. Vaccine, 6: 696-705.
PubMedDirect Link - Halstead, S.B. and S.J. Thomas, 2011. New Japanese encephalitis vaccines: Alternatives to production in mouse brain. Expert Rev. Vaccines, 10: 355-364.
CrossRefPubMedDirect Link - Chokephaibulkit, K., C. Sirivichayakul, U. Thisyakorn, A. Sabchareon and C. Pancharoen et al., 2010. Safety and immunogenicity of a single administration of live-attenuated Japanese encephalitis vaccine in previously primed 2- to 5-year-olds and naive 12- to 24-month-olds: Multicenter randomized controlled trial. Pediatr. Infect. Dis., 29: 1111-1117.
CrossRefPubMedDirect Link - Richner, J.M., S. Himansu, K.A. Dowd, S.L. Butler and V. Salazar et al., 2017. Modified mRNA vaccines protect against Zika virus infection. Cell, 168: 1114-1125.
CrossRefPubMedDirect Link - Pardi, N., M.J. Hogan, R.S. Pelc, H. Muramatsu and H. Andersen, et al., 2017. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination. Nature, 543: 448-451.
CrossRefDirect Link - Larocca, R.A., P. Abbink, J.P.S. Peron, P.M.D.A. Zanotto and M.J. Iampietro et al., 2016. Vaccine protection against Zika virus from Brazil. Nature, 536: 474-478.
CrossRefDirect Link - Dowd, K.A., S.Y. Ko, K.M. Morabito, E.S. Yang and R.S. Pelc et al., 2016. Rapid development of a DNA vaccine for Zika virus. Science, 354: 237-240.
CrossRefPubMedDirect Link - Abbink, P., R.A. Larocca, R.A. De La Barrera, C.A. Bricault and E.T. Moseley et al., 2016. Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys. Science, 353: 1129-1132.
CrossRefPubMedDirect Link - Hampton, T., 2016. DNA vaccine protects monkeys against Zika virus infection. JAMA., Vol. 316, No. 17.
CrossRefDirect Link - Stiasny, K., S. Kiermayr, H. Holzmann and F.X. Heinz, 2006. Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites. J. Virol., 80: 9557-9568.
CrossRefPubMedDirect Link - Dowd, K.A. and T.C. Pierson, 2011. Antibody-mediated neutralization of flaviviruses: A reductionist view. Virology, 411: 306-315.
CrossRefDirect Link - Kennedy, R.B., 2016. Pushing forward with Zika vaccines. EBioMedicine, 13: 29-30.
CrossRefPubMedDirect Link - Kim, E., G. Erdos, S. Huang, T. Kenniston, L.D. Falo Jr. and A. Gambotto, 2016. Preventative vaccines for Zika virus outbreak: Preliminary evaluation. EBioMedicine, 13: 315-320.
CrossRefPubMedDirect Link - Ioos, S., H.P. Mallet, I.L. Goffart, V. Gauthier, T. Cardoso and M. Herida, 2014. Current Zika virus epidemiology and recent epidemics. Med. Mal. Infect., 44: 302-307.
CrossRefDirect Link - Hajra, A., D. Bandyopadhyay, and S.K. Hajra, 2016. Zika virus: A Global threat to humanity: A comprehensive review and current developments. North Am. J. Med. Sci., 8: 123-128.
CrossRefDirect Link - Samarasekera, U. and M. Triunfol, 2016. Concern over Zika virus grips the world. Lancet, 387: 521-524.
CrossRefPubMedDirect Link - Betancourt, D., N.M.G.P. de Queiroz, T. Xia, J. Ahn and G.N. Barber, 2017. Cutting edge: Innate immune augmenting vesicular stomatitis virus expressing Zika virus proteins confers protective immunity. J. Immunol., 198: 3023-3038.
CrossRefDirect Link - Kostyuchenko, V.A., E.X.Y. Lim, S. Zhang, G. Fibriansah and T.S. Ng et al., 2016. Structure of the thermally stable Zika virus. Nature, 553: 425-428.
CrossRefDirect Link - Poland, G.A., I.G. Ovsyannikova, R.B. Kennedy, I.H. Haralambieva and R.M. Jacobson, 2011. Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections. Omics, 15: 625-636.
CrossRefPubMedDirect Link - Mirza, M.U., S. Rafique, A. Ali, M. Munir and N. Ikram, et al., 2016. Erratum: Towards peptide vaccines against Zika virus: Immunoinformatics combined with molecular dynamics simulations to predict antigenic epitopes of Zika viral proteins. Scient. Rep., Vol. 6.
CrossRefDirect Link - Veljkovic, V. and S. Paessler, 2016. Possible repurposing of seasonal influenza vaccine for prevention of Zika virus infection. F1000 Res., Vol. 5.
CrossRefDirect Link - Zhao, H., E. Fernandez, K.A. Dowd, S.D. Speer and D.J. Platt et al., 2016. Structural basis of Zika virus-specific antibody protection. Cell, 166: 1016-1027.
CrossRefPubMedDirect Link - Poland, G.A., R.B. Kennedy, B.A. McKinney, I.G. Ovsyannikova, N.D. Lambert, R.M. Jacobson and A.L. Oberg, 2013. Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century. Semin. immunol., 25: 89-103.
CrossRefPubMedDirect Link - Kennedy, R.B. and G.A. Poland, 2011. The top five game changers in vaccinology: Toward rational and directed vaccine development. Omics, 15: 533-537.
CrossRefPubMedDirect Link - Bonin, C.R.B., G.C. Fernandes, R.W. dos Santos and M. Lobosco, 2017. Mathematical modeling based on ordinary differential equations: a promising approach to vaccinology. Hum. Vaccin. Immunother., 13: 484-489.
CrossRefDirect Link - Ashfaq, U.A. and B. Ahmed, 2016. De novo structural modeling and conserved epitopes prediction of zika virus envelop protein for vaccine development. Viral Immunol., 29: 436-443.
CrossRefDirect Link - Koff, W.C., D.R. Burton, P.R. Johnson, B.D. Walker and C.R. King et al., 2013. Accelerating next-generation vaccine development for global disease prevention. Science, Vol. 340, No. 6136.
CrossRefDirect Link - Singh, R.K., S.K. Badasara, K. Dhama and Y.P.S. Malik, 2015. Progress and prospects in vaccine research. Proceedings of the Chapter in National Workshop on Current Trends and Future Research Challenges in Vaccines and Adjuvants, November 19-20, 2015, ICAR Indian Veterinary Research Institute, Bareilly, Uttar Pradesh, India, pp: 1-19.
- Boigard, H., A. Alimova, G.R. Martin, A. Katz, P. Gottlieb and J.M. Galarza, 2017. Zika Virus-Like Particle (VLP) based vaccine. PLoS Negl. Trop. Dis., Vol. 11, No. 5.
CrossRefDirect Link - Barzon, L., M. Trevisan, A. Sinigaglia, E. Lavezzo and G. Palu, 2016. Zika virus: from pathogenesis to disease control. FEMS Microbiol. Lett., Vol. 363, No. 18.
CrossRefDirect Link - Pierson, T.C. and B.S. Graham, 2016. Zika virus: Immunity and vaccine development. Cell, 167: 625-631.
CrossRefDirect Link - Halstead, S.B., S. Rojanasuphot and N. Sangkawibha, 1983. Original antigenic sin in dengue. Am. J. Trop. Med. Hyg., 32: 154-156.
CrossRefDirect Link - Mongkolsapaya, J., W. Dejnirattisai, X.N. Xu, S. Vasanawathana and N. Tangthawornchaikul et al., 2003. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat. Med., 9: 921-927.
CrossRefPubMedDirect Link - Screaton, G., J. Mongkolsapaya, S. Yacoub and C. Roberts, 2015. New insights into the immunopathology and control of dengue virus infection. Nat. Rev. Immunol., 15: 745-759.
CrossRefPubMedDirect Link - Midgley, C.M., M. Bajwa-Joseph, S. Vasanawathana, W. Limpitikul and B. Wills et al., 2011. An in-depth analysis of original antigenic sin in dengue virus infection. J. Virol. 85: 410-421.
CrossRefDirect Link - Tsai, W.Y., A. Durbin, J.J. Tsai, S.C. Hsieh, S. Whitehead and W.K. Wang, 2015. Complexity of neutralizing antibodies against multiple dengue virus serotypes after heterotypic immunization and secondary infection revealed by in-depth analysis of cross-reactive antibodies. J. Virol., 89: 7348-7362.
CrossRefPubMedDirect Link - Mizumoto, K., K. Ejima, T. Yamamoto and H. Nishiura, 2014. On the risk of severe dengue during secondary infection: A systematic review coupled with mathematical modeling. J. Vector Borne Dis., 51: 153-164.
Direct Link - Martins, K.A.O., J.M. Dye and S. Bavari, 2016. Considerations for the development of Zika virus vaccines. Vaccine, 34: 3711-3712.
CrossRefDirect Link - Flipse, J. and J.M. Smit, 2015. The complexity of a dengue vaccine: A review of the human antibody response. PLoS Negl. Trop. Dis., Vol. 9.
CrossRefDirect Link - Dejnirattisai, W., P. Supasa, W. Wongwiwat, A. Rouvinski and G. Barba-Spaeth et al., 2016. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with Zika virus. Nat. Immunol., 17: 1102-1108.
CrossRefDirect Link - Beck, C., M.A. Jimenez-Clavero, A. Leblond, B. Durand and N. Nowotny et al., 2013. Flaviviruses in Europe: Complex circulation patterns and their consequences for the diagnosis and control of West Nile disease. Int. J. Environ. Res. Public Health, 10: 6049-6083.
CrossRefDirect Link - Paul, L.M., E.R. Carlin, M.M. Jenkins, A.L. Tan and C.M. Barcellona et al., 2016. Dengue virus antibodies enhance Zika virus infection. Clin. Transl. Immunol., Vol. 5.
CrossRefDirect Link - Schlothauer, T., S. Herter, C.F. Koller, S. Grau-Richards and V. Steinhart et al., 2016. Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions. Protein Eng. Des. Sel., 29: 457-466.
CrossRefPubMedDirect Link - Johnson, B.W., O. Kosoy, D.A. Martin, A.J. Noga, B.J. Russell, A.A. Johnson and L.R. Petersen, 2005. West Nile virus infection and serologic response among persons previously vaccinated against yellow fever and Japanese encephalitis viruses. Vector-Borne Zoonotic Dis., 5: 137-145.
CrossRefDirect Link - Izurieta, R.O., M. Macaluso, D.M. Watts, R.B. Tesh and B. Guerra et al., 2009. Anamnestic immune response to dengue and decreased severity of yellow fever. J. Global Infect. Dis., 1: 111-116.
Direct Link
